News Column

BioExx Specialty Proteins Ltd.: Notice of Annual and Q4 2012 Results Conference Call

Mar 19 2013 12:00AM



TORONTO, ONTARIO -- (Marketwire) -- 03/19/13 -- BioExx Specialty Proteins Ltd. ("BioExx" or the "Company") (TSX: BXI), announced today that it will release its financial results for the three and twelve months ended December 31, 2012 following the close of markets on Monday, April 1, 2013. Management will host a conference call on Tuesday, April 2 at 8:30 a.m. (Eastern Time) to review the financial results.

The Company's progress towards completion of a strategic partner transaction has continued throughout the first quarter of 2013, and the Company looks forward to discussing this on its conference call. If there are any material reportable developments in advance of the call, the Company will provide required disclosure in accordance with securities regulation.

Live Conference CallDial-in Numbers: 416-340-8527 / 877-240-9772 / 800-2787-2090Instant Replay:Dial-in Numbers: 905-694-9451 / 800-408-3053 / 800-3366-3052Pass code: 6482893Available Until: April 16, 2013 11:59 PMThe call will be audio-cast live and archived for 90 days at

About BioExx Specialty Proteins Ltd.

Headquartered in Toronto, Canada, BioExx is focused on the separation of oil and high-value proteins from oilseeds for global food, beverage, nutrition, and other markets. BioExx employs trade secret, patented and patent-pending technologies to enable the improved separation of proteins from oilseeds. BioExx believes that these processes cumulatively have the potential to make a valuable contribution to global food and protein supply while maintaining an environmentally sustainable footprint.

To find out more about BioExx Specialty Proteins Ltd. (TSX: BXI), please visit

The statements made in this press release include forward-looking statements that involve a number of risks and uncertainties. These statements relate to future events or future performance and reflect management's current expectations and assumptions. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements, such as the economy, generally, competition in its target markets, the demand for BioExx's products, the availability of funding, the efficacy of its technology, and the anticipated costs of BioExx's plant construction and operation.

These forward-looking statements are made as of the date hereof and BioExx does not assume any obligation to update or revise them to reflect new events or circumstances. Actual events or results could differ materially from BioExx's expectations and projections.

BioExx Specialty Proteins Ltd.:
Chris Schnarr
Chief Executive Officer
(416) 588-4442 x111

Investor Relations:
Brisco Capital Partners
Scott Koyich
(403) 262-9888

Source: Marketwire

Story Tools